NASDAQ:SSKN STRATA Skin Sciences (SSKN) Stock Price, News & Analysis $2.55 +0.08 (+3.24%) As of 01:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock About STRATA Skin Sciences Stock (NASDAQ:SSKN) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get STRATA Skin Sciences alerts:Sign Up Key Stats Today's Range$2.42▼$2.8150-Day Range$2.41▼$2.7252-Week Range$2.10▼$4.30Volume46,526 shsAverage Volume13,089 shsMarket Capitalization$10.64 millionP/E RatioN/ADividend YieldN/APrice Target$6.00Consensus RatingBuy Company OverviewSTRATA Skin Sciences, Inc., a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment. The company products include XTRAC and Pharos excimer lasers, and VTRAC lamp systems for the treatment systems that are used for the treatment of psoriasis, vitiligo, and other skin conditions. It also offers TheraClear Acne Therapy System for the treatment of mild to moderate inflammatory, comedonal, and pustular acne. The company was formerly known as MELA Sciences, Inc and changed its name to STRATA Skin Sciences, Inc. in January 2016. STRATA Skin Sciences, Inc. was incorporated in 1989 and is based in Horsham, Pennsylvania.Read More… STRATA Skin Sciences Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks55th Percentile Overall ScoreSSKN MarketRank™: STRATA Skin Sciences scored higher than 55% of companies evaluated by MarketBeat, and ranked 535th out of 917 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingBuy Consensus RatingSTRATA Skin Sciences has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.Amount of Analyst CoverageSTRATA Skin Sciences has only been the subject of 1 research reports in the past 90 days.Read more about STRATA Skin Sciences' stock forecast and price target. Earnings and Valuation1.3 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for STRATA Skin Sciences are expected to grow in the coming year, from ($1.05) to ($1.04) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of STRATA Skin Sciences is -0.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of STRATA Skin Sciences is -0.94, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioSTRATA Skin Sciences has a P/B Ratio of 0.68. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted0.07% of the float of STRATA Skin Sciences has been sold short.Short Interest Ratio / Days to CoverSTRATA Skin Sciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in STRATA Skin Sciences has recently increased by 58.33%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSTRATA Skin Sciences does not currently pay a dividend.Dividend GrowthSTRATA Skin Sciences does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted0.07% of the float of STRATA Skin Sciences has been sold short.Short Interest Ratio / Days to CoverSTRATA Skin Sciences has a short interest ratio ("days to cover") of 0.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in STRATA Skin Sciences has recently increased by 58.33%, indicating that investor sentiment is decreasing significantly. News and Social Media2.2 / 5News SentimentN/A News SentimentSTRATA Skin Sciences has a news sentiment score of 0.95. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.69 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 1 news article for STRATA Skin Sciences this week, compared to 1 article on an average week. Company Ownership1.7 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, STRATA Skin Sciences insiders have not sold or bought any company stock.Percentage Held by Insiders39.00% of the stock of STRATA Skin Sciences is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by InstitutionsOnly 32.43% of the stock of STRATA Skin Sciences is held by institutions.Read more about STRATA Skin Sciences' insider trading history. Receive SSKN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for STRATA Skin Sciences and its competitors with MarketBeat's FREE daily newsletter. Email Address SSKN Stock News HeadlinesSTRATA Skin Sciences Gains CPT Code Expansion For Excimer Laser Use In Skin Inflammatory DiseasesMay 21 at 11:38 PM | nasdaq.comSTRATA Skin Sciences, Inc. (NASDAQ:SSKN) Q1 2025 Earnings Call TranscriptMay 16, 2025 | insidermonkey.comThink NVDA’s run was epic? You ain’t seen nothin’ yetAsk most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?May 23, 2025 | Timothy Sykes (Ad)STRATA Skin Sciences, Inc. (SSKN) Q1 2025 Earnings Call TranscriptMay 14, 2025 | seekingalpha.comSTRATA Skin Sciences Reports First Quarter 2025 Financial Results and Provides a Corporate UpdateMay 14, 2025 | globenewswire.com3SSKN : A Peek at Strata Skin Sciences's Future EarningsMay 13, 2025 | benzinga.comStrata Skin Sciences Inc (SSKN) Q1 2025: Everything You Need To Know Ahead Of EarningsMay 13, 2025 | finance.yahoo.comSTRATA Skin Sciences to Join D. Boral Capital’s Inaugural Global Conference in NYCMay 11, 2025 | msn.comSee More Headlines SSKN Stock Analysis - Frequently Asked Questions How have SSKN shares performed this year? STRATA Skin Sciences' stock was trading at $2.91 on January 1st, 2025. Since then, SSKN shares have decreased by 14.1% and is now trading at $2.50. View the best growth stocks for 2025 here. How were STRATA Skin Sciences' earnings last quarter? STRATA Skin Sciences, Inc. (NASDAQ:SSKN) announced its quarterly earnings results on Wednesday, May, 14th. The medical device company reported ($0.58) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.56) by $0.02. The medical device company earned $6.81 million during the quarter, compared to the consensus estimate of $7.28 million. STRATA Skin Sciences had a negative trailing twelve-month return on equity of 69.33% and a negative net margin of 28.72%. Read the conference call transcript. When did STRATA Skin Sciences' stock split? STRATA Skin Sciences's stock reverse split on the morning of Friday, June 7th 2024. The 1-10 reverse split was announced on Friday, June 7th 2024. The number of shares owned by shareholders was adjusted after the market closes on Friday, June 7th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split. How do I buy shares of STRATA Skin Sciences? Shares of SSKN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of STRATA Skin Sciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that STRATA Skin Sciences investors own include Amarin (AMRN), AbbVie (ABBV), OPKO Health (OPK), AT&T (T), Agile Therapeutics (AGRX), Advanced Micro Devices (AMD) and Avino Silver & Gold Mines (ASM). Company Calendar Last Earnings5/14/2025Today5/23/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNASDAQ:SSKN CIK1051514 Webwww.strataskinsciences.com Phone(215) 619-3200Fax215-619-3208Employees120Year FoundedN/APrice Target and Rating Average Stock Price Target$6.00 High Stock Price Target$6.00 Low Stock Price Target$6.00 Potential Upside/Downside+136.7%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)($2.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-10,830,000.00 Net Margins-28.72% Pretax Margin-29.00% Return on Equity-69.33% Return on Assets-17.55% Debt Debt-to-Equity Ratio1.62 Current Ratio1.13 Quick Ratio0.94 Sales & Book Value Annual Sales$33.62 million Price / Sales0.31 Cash FlowN/A Price / Cash FlowN/A Book Value$3.65 per share Price / Book0.69Miscellaneous Outstanding Shares4,171,000Free Float2,544,000Market Cap$10.57 million OptionableNot Optionable Beta0.68 Social Links 2025 Gold Forecast: A Perfect Storm for DemandUnlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.Get This Free Report This page (NASDAQ:SSKN) was last updated on 5/23/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon Set to Shock the World on June 1st?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredWhy Elon put $51 million into thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredNow I look stupid. Real stupid... I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STRATA Skin Sciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share STRATA Skin Sciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.